Science & Technology
The significance of our proprietary platforms remain in their ability to overcome issues related to stability and effectiveness even in the presence of blood serum.
We have created formulas that drastically reduce disinfection and sterilization times while eradicating biofilms when diluted >98%.
Current Problem
Antibiotic resistant pathogens and Biofilms can be found almost anywhere, are virtually impossible to eradicate on hard surfaces and wounds, and remain highly contagious.
Unmet Need
There are no safe and effective therapies to eradicate antibiotic resistant pathogens, spores, and biofilms in wounds and on hard surfaces on the market today.
Our Platforms
Our safe and non-toxic formulations of PKU-151 successfully eradicates biofilms in wounds even after 50% dilution. Our PKU-60 formula for hard surface and medical device sterilization eradicates biofilm at full strength down to 99.8% dilution.
R&D and Manufacturing
Our 14,000 sq. ft. Corporate Headquarters is based in Petaluma, California.
Our cGMP registered manufacturing and bottling plant will be capable initially of producing over 20,000 units per hour.
We intend to manufacture both EPA and FDA approved products using a highly experienced quality control and regulatory team.
